ITRM20020555A0 - Forma cristallina anidra di cloridrato di valaciclovir. - Google Patents
Forma cristallina anidra di cloridrato di valaciclovir.Info
- Publication number
- ITRM20020555A0 ITRM20020555A0 IT2002RM000555A ITRM20020555A ITRM20020555A0 IT RM20020555 A0 ITRM20020555 A0 IT RM20020555A0 IT 2002RM000555 A IT2002RM000555 A IT 2002RM000555A IT RM20020555 A ITRM20020555 A IT RM20020555A IT RM20020555 A0 ITRM20020555 A0 IT RM20020555A0
- Authority
- IT
- Italy
- Prior art keywords
- crystalline form
- anhydrous crystalline
- valaciclovir hydrochloride
- valaciclovir
- hydrochloride
- Prior art date
Links
- ZCDDBUOENGJMLV-QRPNPIFTSA-N Valacyclovir hydrochloride Chemical compound Cl.N1C(N)=NC(=O)C2=C1N(COCCOC(=O)[C@@H](N)C(C)C)C=N2 ZCDDBUOENGJMLV-QRPNPIFTSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US33331301P | 2001-11-05 | 2001-11-05 | |
| PCT/US2002/033926 WO2003040145A1 (en) | 2001-11-05 | 2002-10-23 | Anhydrous crystal form of valaciclovir hydrochloride |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ITRM20020555A0 true ITRM20020555A0 (it) | 2002-11-05 |
| ITRM20020555A1 ITRM20020555A1 (it) | 2003-05-06 |
Family
ID=23302261
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IT000555A ITRM20020555A1 (it) | 2001-11-05 | 2002-11-05 | Forma cristallina anidra di cloridrato di valaciclovir. |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US20040197396A1 (it) |
| EP (1) | EP1453834A1 (it) |
| JP (1) | JP2005511612A (it) |
| AU (1) | AU2002348022B2 (it) |
| CA (1) | CA2465420A1 (it) |
| FR (1) | FR2831885A1 (it) |
| GB (1) | GB2383038B (it) |
| GR (1) | GR1004358B (it) |
| IT (1) | ITRM20020555A1 (it) |
| WO (1) | WO2003040145A1 (it) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5043286B2 (ja) * | 2001-09-07 | 2012-10-10 | テバ ファーマシューティカル インダストリーズ リミティド | バラシクロビル塩酸塩の結晶型 |
| US20040197396A1 (en) * | 2001-11-05 | 2004-10-07 | Fain Helen S | Anhydrous crystal form of valaciclovir hydrochloride |
| PL371732A1 (en) * | 2001-11-14 | 2005-06-27 | Teva Pharmaceutical Industries Ltd. | Synthesis and purification of valacyclovir |
| US20050043329A1 (en) * | 2002-09-06 | 2005-02-24 | Shlomit Wizel | Crystalline forms of valacyclovir hydrochloride |
| CA2548608A1 (en) * | 2002-12-09 | 2004-06-24 | Texcontor Etablissement | Anhydrous crystalline form of valacyclovir hydrochloride |
| EP1633753A1 (en) * | 2003-05-30 | 2006-03-15 | EOS Eczacibasi Ozgun Kimyasal Urunler Sanayi Ve Ti Caret A.S. | Novel crystalline forms of valacyclovir hydrochloride |
| EP1638972A2 (en) * | 2003-06-02 | 2006-03-29 | Teva Pharmaceutical Industries Limited | Novel crystalline forms of valacyclovir hydrochloride |
| CN1331471C (zh) * | 2003-09-22 | 2007-08-15 | 陈云芳 | 盐酸万乃洛韦软胶囊组合物 |
| EP1746098A1 (en) | 2005-07-21 | 2007-01-24 | SOLMAG S.p.A. | Valacyclovir polymorphs and a process for the preparation thereof |
| US20080167325A1 (en) * | 2006-12-27 | 2008-07-10 | Bs Praveen Kumar | Valacyclovir compositions |
| JPWO2009031576A1 (ja) * | 2007-09-03 | 2010-12-16 | 味の素株式会社 | バラシクロビル塩酸塩結晶の製造方法 |
| WO2011158252A1 (en) | 2010-06-15 | 2011-12-22 | Matrix Laboratories Ltd | Process for the preparation of valacyclovir hydrochloride polymorphic form ii |
| CN105753868B (zh) * | 2016-04-12 | 2017-08-01 | 浙江理工大学 | 一种盐酸伐昔洛韦的半水合物及其制备方法 |
| CN112176011B (zh) * | 2020-10-26 | 2022-10-18 | 辰欣药业股份有限公司 | 一种酶催化制备盐酸伐昔洛韦的方法 |
| CN116754538B (zh) * | 2023-06-15 | 2024-05-07 | 深圳市新阳唯康科技有限公司 | 一种阿昔洛韦软膏的晶型定量方法 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4199574A (en) * | 1974-09-02 | 1980-04-22 | Burroughs Wellcome Co. | Methods and compositions for treating viral infections and guanine acyclic nucleosides |
| GB8719367D0 (en) * | 1987-08-15 | 1987-09-23 | Wellcome Found | Therapeutic compounds |
| GB9501178D0 (en) * | 1995-01-20 | 1995-03-08 | Wellcome Found | Guanine derivative |
| GB9501127D0 (en) * | 1995-01-20 | 1995-03-08 | Wellcome Found | Tablet |
| JP5043286B2 (ja) * | 2001-09-07 | 2012-10-10 | テバ ファーマシューティカル インダストリーズ リミティド | バラシクロビル塩酸塩の結晶型 |
| US20040197396A1 (en) * | 2001-11-05 | 2004-10-07 | Fain Helen S | Anhydrous crystal form of valaciclovir hydrochloride |
| PL371732A1 (en) * | 2001-11-14 | 2005-06-27 | Teva Pharmaceutical Industries Ltd. | Synthesis and purification of valacyclovir |
| US20050043329A1 (en) * | 2002-09-06 | 2005-02-24 | Shlomit Wizel | Crystalline forms of valacyclovir hydrochloride |
| US20050059684A1 (en) * | 2002-10-16 | 2005-03-17 | Ben-Zion Dolitzky | Method for reducing residual alcohols in crystalline valacyclovir hydrochloride |
| WO2004035583A1 (en) * | 2002-10-16 | 2004-04-29 | Teva Pharmaceutical Industries Ltd. | Method for reducing residual alcohols in crystalline valacyclovir hydrochloride |
| CA2548608A1 (en) * | 2002-12-09 | 2004-06-24 | Texcontor Etablissement | Anhydrous crystalline form of valacyclovir hydrochloride |
| EP1633753A1 (en) * | 2003-05-30 | 2006-03-15 | EOS Eczacibasi Ozgun Kimyasal Urunler Sanayi Ve Ti Caret A.S. | Novel crystalline forms of valacyclovir hydrochloride |
| EP1638972A2 (en) * | 2003-06-02 | 2006-03-29 | Teva Pharmaceutical Industries Limited | Novel crystalline forms of valacyclovir hydrochloride |
| WO2005073233A1 (en) * | 2004-01-21 | 2005-08-11 | Teva Pharmaceutical Industries Ltd. | Process for the preparation of valacyclovir hydrochloride |
| EP1746098A1 (en) * | 2005-07-21 | 2007-01-24 | SOLMAG S.p.A. | Valacyclovir polymorphs and a process for the preparation thereof |
| US20070112193A1 (en) * | 2005-11-14 | 2007-05-17 | Khunt Mayur D | Valacyclovir process |
-
2002
- 2002-10-23 US US10/494,115 patent/US20040197396A1/en not_active Abandoned
- 2002-10-23 WO PCT/US2002/033926 patent/WO2003040145A1/en active Application Filing
- 2002-10-23 AU AU2002348022A patent/AU2002348022B2/en not_active Ceased
- 2002-10-23 CA CA002465420A patent/CA2465420A1/en not_active Abandoned
- 2002-10-23 EP EP02784234A patent/EP1453834A1/en not_active Withdrawn
- 2002-10-23 JP JP2003542191A patent/JP2005511612A/ja active Pending
- 2002-11-04 FR FR0213752A patent/FR2831885A1/fr not_active Withdrawn
- 2002-11-05 IT IT000555A patent/ITRM20020555A1/it unknown
- 2002-11-05 GB GB0225771A patent/GB2383038B/en not_active Expired - Fee Related
- 2002-11-05 GR GR20020100478A patent/GR1004358B/el unknown
-
2006
- 2006-10-24 US US11/552,218 patent/US20070093511A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| JP2005511612A (ja) | 2005-04-28 |
| EP1453834A1 (en) | 2004-09-08 |
| US20040197396A1 (en) | 2004-10-07 |
| GR20020100478A (el) | 2003-07-16 |
| WO2003040145A1 (en) | 2003-05-15 |
| GR1004358B (el) | 2003-10-07 |
| GB2383038B (en) | 2005-01-19 |
| US20070093511A1 (en) | 2007-04-26 |
| GB2383038A (en) | 2003-06-18 |
| GB0225771D0 (en) | 2002-12-11 |
| CA2465420A1 (en) | 2003-05-15 |
| AU2002348022B2 (en) | 2006-06-15 |
| ITRM20020555A1 (it) | 2003-05-06 |
| FR2831885A1 (fr) | 2003-05-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1451192T3 (da) | Ny krystallinsk forbindelse | |
| CY2015035I1 (el) | Ενωσεις πυριμιδινης | |
| NO20025719L (no) | Nye triazolpyrimidinforbindelser | |
| EE200300575A (et) | Asitromütsiini kristalsed vormid | |
| DE60234125D1 (de) | E inhibitoren | |
| NO20024127D0 (no) | Pyrimidin-forbindelser | |
| DK1370553T3 (da) | Rho-kinase-inhibitorer | |
| DK1370552T3 (da) | Rho-kinase-inhibitorer | |
| IS7287A (is) | Pýrimídín efnasambönd | |
| ITRM20020555A0 (it) | Forma cristallina anidra di cloridrato di valaciclovir. | |
| NO20033679D0 (no) | Nye pyrimidinforbindelser | |
| ATE430755T1 (de) | Wasserfreies kristallines azidocytosin-hemisulfat-derivat | |
| NO20055097D0 (no) | Krystallinske N-formyl-hydroksylaminforbindelser | |
| NO20030416D0 (no) | Krystallinsk terapeutisk forbindelse | |
| ITMI20020488A1 (it) | Forma cristallina di venlafaxina cloridrato | |
| DE60219659D1 (de) | Heterocyclische retioidverbindungen | |
| ITMI20030638A1 (it) | Forma cristallina di cefdinir | |
| IS7169A (is) | Kristölluð form valasýklóvírhýdróklóríðs | |
| ITAN20020053A1 (it) | Meccanismo di trasformazione di qualsiasi macchina | |
| NO20033761D0 (no) | Silisium-krystallisasjon | |
| ITMI20020072A1 (it) | Dispositivo di cristallizzazione | |
| ITMI20020066A1 (it) | Struttura di parete | |
| SE0100965D0 (sv) | Pharmaceutically-useful compounds | |
| SE0103802D0 (sv) | Novel compound | |
| SE0001187D0 (sv) | Crystalline form |